REPROS THERAPEUTICS INC. (RPRX) [Rocket]

In millions, except per share items	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Total revenues [+]	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6
Royalties				23.7	14.1	8.7
Net interest income				0.0	0.0	0.0		0.0
Revenue growth	327.3%	22.2%	0.0%	200.0%	50.0%	-99.5%	-23.6%	27.3%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Selling, general and administrative [+]	4.6	5.1	5.4	4.8	4.8	3.8	2.3	4.7
General and administrative	4.6	5.1	5.4	4.8	4.8	3.8	2.3	4.7
Research and development	12.8	24.1	27.1	23.7	14.1	8.7	2.9	23.1
Other operating expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6
EBITDA [+]	-17.3	-29.2	-32.5	-28.4	-18.9	-12.4	-5.1	-27.7
EBITDA growth	-40.7%	-10.2%	14.3%	50.2%	52.9%	142.6%	-81.6%	10.2%
EBITDA margin	-36840.4%	-265263.6%	-361122.2%	-315944.4%	-631033.3%	-618900.0%	-1211.9%	-5029.6%
Depreciation and amortization	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1
EBIT [+]	-17.3	-29.2	-32.5	-28.5	-18.9	-12.5	-5.2	-27.8
EBIT growth	-40.7%	-10.3%	14.3%	50.3%	51.7%	140.8%	-81.3%	10.2%
EBIT margin	-36851.1%	-265481.8%	-361600.0%	-316388.9%	-631566.7%	-624650.0%	-1232.5%	-5042.6%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0		0.0
Interest income	0.0	0.0	0.0	0.0	0.0	0.0		0.0
Other income (expense), net [+]							0.4	0.5
Other non-operating income							0.4	0.5
Other							0.4	0.5
Pre-tax income	-17.3	-29.2	-32.5	-28.5	-18.9	-12.5	-4.8	-27.2
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-17.3	-29.2	-32.5	-28.5	-18.9	-12.5	-4.8	-27.2
Net margin	-36751.1%	-265381.8%	-361500.0%	-316288.9%	-631466.7%	-624550.0%	-1132.5%	-4942.6%

Basic EPS [+]	($0.70)	($1.20)	($1.39)	($1.37)	($1.23)	($1.04)	($0.59)	($6.28)
Growth	-41.7%	-13.5%	1.5%	10.8%	18.2%	76.5%	-90.6%	-16.7%
Diluted EPS [+]	($0.70)	($1.20)	($1.39)	($1.37)	($1.23)	($1.04)	($0.59)	($6.28)
Growth	-41.7%	-13.5%	1.5%	10.8%	18.2%	76.5%	-90.6%	-16.7%

Shares outstanding (basic) [+]	24.7	24.3	23.4	20.8	15.3	12.0	8.1	4.3
Growth	1.5%	3.7%	12.6%	35.6%	28.3%	48.5%	85.8%	29.7%
Shares outstanding (diluted) [+]	24.7	24.3	23.4	20.8	15.3	12.0	8.1	4.3
Growth	1.5%	3.7%	12.6%	35.6%	28.3%	48.5%	85.8%	29.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.